跳至主要内容
临床试验/NCT00371774
NCT00371774已完成不适用

Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) Program

Astellas Pharma Inc0 个研究点目标入组 426 人开始时间: 2005年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
426
主要终点
Understand how AMEVIVE is used in routine clinical practice/real world setting

研究概览

简要总结

Purpose:

To develop a real time national clinical database to support and share best practices,

  1. To generate hypotheses for future clinical research
  2. To understand how AMEVIVE is used in routine clinical practice/real world setting.

Each patient visit will include the following observational endpoints:

  1. AMEVIVE dosing
  2. Number of courses
  3. Concomitant treatment
  4. Response to treatment (patient and physician global assessments)
  5. Status of other psoriasis-related medical conditions
  6. Time to re-treatment.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Amevive is clinically indicated for the patient

排除标准

  • Amevive is contraindicated for the patient

结局指标

主要结局

Understand how AMEVIVE is used in routine clinical practice/real world setting

时间窗: End of study

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Amevive Wisdom Acquired From Real-Time Evidence... | 临床试验